The following presenters have financial relationships with ineligible organizations, however the presentations are not topically related to any healthcare products used on patients that are produced, sold, re-sold, or distributed by the specified company/ companies. All relevant financial relationships have been mitigated.
|Sean||Edwards||Stryker CMF: consulting, honoraria; Consultant fixation, navigation, virtual planning.|
|Brooke||French||I have a profit share agreement with Le Ver LLC and have collected no payment/contract income from this skin care line. None of my presentations discuss products produced by Le Ver LLC.|
|Steven||Goudy||I am the CEO of Dr NozeBest a cold care company. None of my presentations will discuss Dr Noze Best.|
|Matthew||Greives||1) Novartis- consultant. I provided medical expertise to discuss how to develop patient information (websites, brochures, videos) regarding their disease state/diagnosis of vascular anomalies. None of this is related to cleft lip and or palate. 2) KLS – research grant. We were provided with an unrestricted research grant from KLS for our division. This will be used to augment researcher’s salaries. The current researcher who is supported by this grant is not included as an author on any of talks and is not attending the meeting this year. 3) None of our talks discuss either Novartis or KLS or their products.|
|Christopher||Hillyar||1) Scientific consultancy services for AOR Canada. My presentations do no discuss products produced by AOR Canada. 2). Director of Medalytica UK, a not for profit research and teaching organization|
|Tiffany||Hodges||Consultant for Medtronic. I provide consulting work with Medtronic on new and upcoming technology for neurosurgical procedures. I provide feedback and methods of improvement for neurosurgery technology.|
|Richard||Hopper||Inventor of patented nasal molding device licensed through Seattle Childrens to KLS Martin. The device or any KLS products will not be discussed or part of this presentation.|
|Noor||Jeelani||Consultant with KLS Martin. Occasionally lecture and provide workshop advice for KLS. The last time was in 2020. None of my presentations have any relation to this product.|
|Steven||Kasten||Stock owned: Pfizer, Merck, Vertex Pharmaceuticals, Hologic Inc.|
|Anand||Kumar||KLS Martin: Resident research grant 25k per year to support basic science and clinical research costs. No salary support. No specific use of KLS products are in the abstracts or research.|
|Marius George||Linguraru||1) Co-founder and ownership in PediaMetrix, Inc. 2) Intellectual property through Children’s National Hospital, including licensing to MGeneRx Inc, a photo-based facial analysis software technology for the identification of genetic dysmorphia. 3) Funding from Philips Healthcare. No products produced by Phillips Healthcare discussed in any presentations.|
|Sybill||Naidoo||Hanger Clinic: Speaker regarding Deformational plagiocephaly treatment. This does not relate to any presentations.|
|David||Otterburn||1)BD Bard – Consultant: No presentations discuss productes produces by BD Bard. 2) Axogen – Receive research support an investigator initiated study on use of nerve grafts in breast reconstruction. No presentations discuss products produces by Axogen|
|Kamlesh||Patel||1) Consultant for Stryker CMF: Aid in product design (not related to MEDPOR) and facial trauma education. 2) Advisory board for NanoMAG.|
|Gregory||Pearson||Gilead Pharmaceuticals (own stock), Amgen (own stock). No medications discussed in any presentations.|
|Jordan||Swanson||1) Royalties from Springer for textbook, Global Cleft Care in Low-Resource Settings, which go into a fund for training in low resource settings.
2) Developed educational content for DePuy Synthes. None of the presentations discuss products produced by Synthes.
|Jesse||Taylor||Dr. Taylor is co-founder and CMO of Ostiio, LLC. Ostiio (Ostiio.com) has no products on the market currently. None of my presentations relate to Ostiio in any way.|
|Matthew||Wood||1) Consultant for AxoGen Inc. 2) Consultant for Renerva Inc . 3 Checkpoint Surgical Inc: Recipient of research grant. Note: No products produces by Axo Gen, Rewnerva or Checkpoint Surgical are discussed in any presentations.|